GIP Receptor Enhances insulin sensitivity, promotes fat burning, and amplifies GLP-1 activity
Treatment discontinuation due to adverse event occurred in 4% to 11% of retatrutide-treated participants compared with 5% on placebo
Those with a BMI of 30 or Greater: For individuals classified as obese based on their BMI, Semaglutide provides an option to aid in weight reduction and management, thereby reducing the risks associated with obesity, including heart disease, stroke, and certain types of cancer
PlexusDx maps your unique pathway to help your provider optimize treatment before side effects escalate
If you miss a meal, or if your meal contains no fat, do not take a capsule.Linestatdoes not work unless the meal contains some fat, Swallow the capsule whole with water, Do not take more than three capsules a day
de MaturanaRLWillshawAKuntzschARudolphRDonnellyD